Vitamin Shoppe Inc (NYSE:VSI) major shareholder Vintage Capital Management Llc bought 133,804 shares of the stock in a transaction that occurred on Tuesday, January 2nd. The shares were purchased at an average cost of $4.28 per share, with a total value of $572,681.12. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
Vintage Capital Management Llc also recently made the following trade(s):
- On Friday, January 5th, Vintage Capital Management Llc acquired 326,692 shares of Vitamin Shoppe stock. The shares were acquired at an average price of $4.96 per share, with a total value of $1,620,392.32.
- On Saturday, December 29th, Vintage Capital Management Llc acquired 234,343 shares of Vitamin Shoppe stock. The shares were acquired at an average price of $4.36 per share, with a total value of $1,021,735.48.
Shares of Vitamin Shoppe Inc (NYSE:VSI) traded down $0.25 during trading hours on Thursday, reaching $5.00. 921,300 shares of the company traded hands, compared to its average volume of 959,114. The stock has a market capitalization of $119.89, a PE ratio of -0.47 and a beta of 0.68. Vitamin Shoppe Inc has a 12 month low of $2.95 and a 12 month high of $23.85. The company has a current ratio of 2.07, a quick ratio of 0.32 and a debt-to-equity ratio of 0.59.
Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings data on Wednesday, November 8th. The specialty retailer reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.20). Vitamin Shoppe had a negative net margin of 20.27% and a positive return on equity of 6.17%. The firm had revenue of $288.20 million for the quarter, compared to analysts’ expectations of $297.61 million. During the same period in the prior year, the firm posted $0.50 EPS. Vitamin Shoppe’s revenue was down 8.5% on a year-over-year basis. equities analysts anticipate that Vitamin Shoppe Inc will post 0.34 earnings per share for the current year.
Institutional investors have recently made changes to their positions in the company. Macquarie Group Ltd. purchased a new stake in shares of Vitamin Shoppe in the 3rd quarter valued at $101,000. BNP Paribas Arbitrage SA raised its holdings in Vitamin Shoppe by 2.1% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after buying an additional 192 shares during the last quarter. Municipal Employees Retirement System of Michigan raised its holdings in Vitamin Shoppe by 18.1% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock valued at $110,000 after buying an additional 1,440 shares during the last quarter. Wolverine Trading LLC bought a new stake in Vitamin Shoppe during the 2nd quarter valued at $131,000. Finally, UBS Asset Management Americas Inc. raised its holdings in Vitamin Shoppe by 17,041.4% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock valued at $140,000 after buying an additional 11,929 shares during the last quarter. 90.35% of the stock is owned by institutional investors.
VSI has been the topic of a number of recent analyst reports. ValuEngine lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Barclays lowered their price objective on shares of Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $7.50 price objective (down previously from $8.00) on shares of Vitamin Shoppe in a research report on Monday, October 2nd. Finally, Zacks Investment Research lowered shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Tuesday, November 7th. Four research analysts have rated the stock with a sell rating and five have given a hold rating to the company. The stock presently has an average rating of “Hold” and an average price target of $5.00.
COPYRIGHT VIOLATION WARNING: This piece was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/01/11/vitamin-shoppe-inc-vsi-major-shareholder-vintage-capital-management-llc-purchases-133804-shares-of-stock.html.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.